Skip to content

Helping Patients Breathe Easier, Do More & Enjoy Life1

Zephyr® Valves are a Proven Treatment for Breathlessness from Severe COPD/Emphysema

Device-on-White-1080x1080

Helping Patients Breathe Easier, Do More & Enjoy Life1

Zephyr® Valves are a
Proven Treatment for
Breathlessness
from Severe
COPD/Emphysema

Device-on-White-1080x1080
Pulmonx

Breakthrough Technology for Severe COPD/Emphysema

The Zephyr Valve is a clinically-proven bronchoscopic treatment for patients with severe COPD/emphysema – without surgery and its associated risks.1-5

Zephyr Valves: Most Studied. Most Proven. Most Used Valves for Severe COPD/Emphysema1

  • Demonstrated clinically meaningful benefits in lung function, exercise capacity, and quality of life (QoL).1
  • Clinically-proven, safe and effective treatment for patients with severe emphysema
  • Consistent clinical findings across four randomized control trials
Pulmonx

Lung Function (FEV1%) Improvement over Control1

Pulmonx

Exercise Capacity (6MWD) Improvement over Control1

Pulmonx

Quality of Life (SGRQ) Improvement Over Control1

Pulmonx

Selecting the Right Patient

Appropriate patient selection is critical to the success of Zephyr Valve treatment. Over time, clinical trial data have helped define the successful patient profile.1-4,6,7

Selecting the Right Patient

Appropriate patient selection is critical to the success of Zephyr Valve treatment. Over time, clinical trial data have helped define the successful patient profile.1-4,6,7

 

Programs & Webinars

Access a library of peer-to-peer and CME resources created by leading medical societies, pulmonologists, and Medscape.

Real Patients Share Their Experiences with Zephyr Valves

US-EN-2232-v2
US-EN-2232-v2
Pulmonx

Learn More About How Zephyr Valves Work

The procedure reduces hyperinflation, an underlying cause of breathlessness for patients with severe COPD/emphysema.

Pulmonx

Learn More About How Zephyr Valves Work

The procedure reduces hyperinflation, an underlying cause of breathlessness for patients with severe COPD/emphysema.